FAQ

Microparticle Enzyme Immunoassay

Known as: MEIA 
A type of enzyme immunoassay that uses antigen-coated microparticles as a substrate for antibody binding.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-2016
0102019832016

Related topics

Related topics

1 relation
Clinical Data Interchange Standards Consortium Terminology

Related mentions per year

Related mentions per year

1983-2018
19801990200020102020
Microparticle Enzyme Immunoassay
Clinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
BACKGROUND Tacrolimus is a potent immunosuppressive drug used in organ transplantation. Because of its substantial toxic effects… (More)
Is this relevant?
2007
2007
Determination of everolimus in whole blood using the Abbott IMx sirolimus microparticle enzyme immunoassay.
OBJECTIVES Everolimus (Certican) is a new immunosuppressant derived from sirolimus (Rapamune) with a 2-hydroxyethyl chain at… (More)
Is this relevant?
2006
2006
Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus.
OBJECTIVES This study evaluated the analytical characteristics of the new Abbott microparticle enzyme immunoassay (MEIA) for… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 4
Is this relevant?
2005
2005
Low hematocrit and serum albumin concentrations underlie the overestimation of tacrolimus concentrations by microparticle enzyme immunoassay versus liquid chromatography-tandem mass spectrometry.
BACKGROUND Rapid liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods are used increasingly for tacrolimus (TRL… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2004
2004
Hepatitis C virus infection at Sharkia Governorate, Egypt: seroprevalence and associated risk factors.
Because many persons with chronic hepatitis C virus (HCV) infection are asymptomatic, population based serologic studies are… (More)
Is this relevant?
2002
2002
Interference of hematocrit in the tacrolimus II microparticle enzyme immunoassay.
The authors studied the effect of hematocrit, bilirubin, and alkaline phosphatase on microparticle enzyme immunoassay for… (More)
Is this relevant?
2001
2001
Automated detection of the G20210A prothrombin mutation using the LCx microparticle enzyme immunoassay.
BACKGROUND The prothrombin mutation, a G/A transition at position 20210 in the 3' untranslated region of the prothrombin gene, is… (More)
Is this relevant?
2000
2000
The quantification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in renal transplant recipients.
BACKGROUND Sirolimus, an immunosuppressive agent, is undergoing clinical trials in the prophylaxis of organ rejection… (More)
Is this relevant?
1998
1998
Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients.
We evaluated the MEIA II with blood samples with added tacrolimus (3.0, 5.0, 11.0, and 22.0 microg/L). The assay had acceptable… (More)
  • table 1
  • figure 2
  • figure 1
Is this relevant?
1992
1992
Automated microparticle enzyme immunoassay for neural thread protein in cerebrospinal fluid from Alzheimer's disease patients.
An automated microparticle enzyme immunoassay (MEIA) with the IMx analyzer for the detection of neural thread protein (NTP) in… (More)
Is this relevant?